ChIPseq analysis of changes in binding of TFCP2L1 antibody in B16F0 cells in response to SX-682 treatment.
Ontology highlight
ABSTRACT: To define the activity of TFCP2L1 following CXCR2 perturbation, we performed chromatin immunoprecipitation and sequencing analysis (CHIPseq) on B16F0 tumorigenic melanoma cells following treatment with vehicle or SX-682.
ORGANISM(S): Mus musculus
PROVIDER: GSE223289 | GEO | 2023/06/07
REPOSITORIES: GEO
ACCESS DATA